The effect of plasmapheresis on plasma cholinesterase levels in a patient with organophosphate poisoning

Human and Experimental Toxicology

Volumn 23, Issue 7, 2004, Pages 365-368

  Güven, Muhammet ^a   Sungur, Murat ^a   Eser, Bülent ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Atropine; Cholinesterase; Organophosphate; Oxime; Plasmapheresis; Poisoning

Indexed keywords

AMIKACIN; ATROPINE; CHOLINESTERASE; FENITROTHION; IMIPENEM; PRALIDOXIME;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; BACTERIAL INFECTION; CASE REPORT; CHOLINESTERASE BLOOD LEVEL; CLINICAL FEATURE; FOLLOW UP; HUMAN; INTOXICATION; MALE; OUTCOMES RESEARCH; PLASMAPHERESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS; TREATMENT OUTCOME;

ANTIDOTES; ATROPINE; CHOLINESTERASE REACTIVATORS; CHOLINESTERASES; FENITROTHION; HUMANS; INSECTICIDES; MALE; MIDDLE AGED; PLASMAPHERESIS; PRALIDOXIME COMPOUNDS; TREATMENT OUTCOME;

EID: 4344716165     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327104ht462cr     Document Type: Article

References (23)

1. Naik B, Hirshhorn S, Dharnidharka VR. Prolonged neuromuscular block due to cholinesterase depletion by plasmapheresis. J Clin Anesth 2002; 14: 381-84.
2. Busund R, Koukline V, Utrobin U, Nedashkovsky E. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med 2002; 28: 1434-39.
3. Weinstein R. Therapeutic apheresis in neurological disorders. J Clin Apheresis 2000; 15: 74-128.
4. Guven M, Sungur M, Tanriverdi F, Eser B, Kekec Z. Evaluation of the patients with acute intoxication. Turk J Med Sci 2002; 32: 169-72.
5. Eddleston M, Szinicz L, Eyer P, Buckley N. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. Q J Med 2002; 95: 275-83.
6. Sivagnanam S. Potential therapeutic agents in the management of organophosphorus poisoning. Crit Care 2002; 6: 260-61.
7. de Silva HJ, Wijewickrema R, Senanayake N. Does pralidoxime affect outcome of management in acute organophosphorus poisoning? Lancet 1992; 339: 1136-38.
8. Sudakin DL, Mullins ME, Horowitz BZ, Abshier V, Letzig L. Intermediate syndrome after malathion ingestion despite continuous infusion of pralidoxime. J Toxicol Clin Toxicol 2000; 38: 47-50.
9. Johnson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA, Marrs TC, Szinicz L, Vale JA, Haines JA. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg Med 2000; 12: 22-37.
10. Masson F, Froment MT, Bartels CF, Lockridge O. Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase. Biochem J 1997; 325: 53-61.
11. Sungur M, Guven M. Intensive care management of organophosphate insecticide poisoning. Crit Care 2001; 5: 211-15.
12. Aygun D, Doganay Z, Altintop L, Guven H, Onar M, Deniz T, Sunter T. Serum acetylcholinesterase and prognosis of acute organophosphate poisoning. J Toxicol Clin Toxicol 2002; 40: 903-10.
13. Balali-Mood M, Shariat M. Treatment of organophosphate poisoning. Experience of nerve agents and acute pesticide poisoning on the effects of oximes. J Physiol Paris 1998; 92: 375-78.
14. Epstein HM, Jarzemsky D, Zuckerman L, Vagher P. Plasma cholinesterase activity in bank blood. Anesth Analg 1980; 59: 211-14.
15. Jenkins T, Balinsky D, Patient DW. Cholinesterase in plasma: first reported absence in the Bantu; half-life determination. Science 1967; 156: 1748-50.
16. Smith DC, Ridley SA, Donaldson KF. Fresh frozen plasma and edrophonium in a patient with a plasma cholinesterase deficiency. Anaesthesia 1993; 48: 511-13.
17. Zhong P, Wang Q, Sheng H. Alteration of banked blood cholinesterase level and its significance in emergency treatment of acute organophosphorus pesticide poisoning. Zhonghua Nei Ke Za Zhi 2000; 39: 658-59. (Medline abstract)
18. Khan S, Hemalatha R, Jeyaseelan L, Oommen A, Zachariah A. Neuroparalysis and oxime efficacy in organophosphate poisoning: a study of butyrylcholinesterase. Hum Exp Toxicol 2001; 20: 169-74.
19. Raveh L, Grunwald J, Marcus D, Papier Y, Cohen E, Ashani Y. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity: in vitro and in vivo quantitative characterization. Biochem Pharmacol 1993; 45: 2465-74.
20. Broomfield CA, Maxwell DM, Solana RP, Castro CA, Finger AV, Lenz DE. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J Pharmacol Exp Ther 1991; 259: 633-38.
21. Grunwald J, Marcus D, Papier Y, Raveh L, Pittel Z, Ashani Y. Large-scale purification and long-term stability of human butyrylcholinesterase: a potential bioscavenger drug. J Biochem Biophys Methods 1997; 34: 123-35.
22. Li B, Stribley JA, Ticu A, Xie W, Schopfer LM, Hammond P, Brimijoin S, Hinrichs SH, Lockridge O. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J Neurochem 2000; 75: 1320-31.
23. Karalliedde L. Organophosphorus poisoning and anaesthesia. Anaesthesia 1999; 54: 1073-88.